Baxter International (BAX) Stock Price, News & Analysis

Company Overview

Baxter International Inc. (NYSE: BAX) is a global medical products company dedicated to saving and sustaining lives. Founded in 1931 by Dr. Ralph Stephens and Dr. Donald Baxter, the company initially focused on intravenous solutions and has since expanded its offerings to include a broad array of products and therapies. Baxter operates through two primary business segments: Hospital Products, which provides infusion systems, parenteral nutrition, and surgical care products; and Kidney Care, delivering dialysis equipment, related disposables, and renal pharmaceuticals.

Today, Baxter’s portfolio encompasses advanced drug delivery systems, biosurgery products, nutritional therapies, and renal care technologies. Its infusion systems facilitate precise delivery of critical medications in hospitals and outpatient settings, while its biosurgery division offers hemostats, sealants, and tissue repair solutions. In kidney care, Baxter supplies hemodialysis and peritoneal dialysis equipment along with dialysis-related disposables and therapies that serve patients with chronic kidney disease at home and in clinical environments.

Headquartered in Deerfield, Illinois, Baxter maintains operations in more than 100 countries across North America, Europe, Latin America, Asia-Pacific, and the Middle East. Under the leadership of Chairman and Chief Executive Officer José E. Almeida, the company emphasizes innovation, operational excellence, and patient-centric solutions. Baxter’s extensive global reach, combined with its commitment to research and development, positions it as a key partner for healthcare providers seeking reliable and effective medical technologies.

Key Stats

• Today's Range: $30.88 to $31.22
• 50-Day Range: $29.54 to $31.88
• 52-Week Range: $26.25 to $40.49
• Volume: 1.43 million shs
• Average Volume: 4.37 million shs
• Market Capitalization: $15.95 billion
• P/E Ratio: N/A
• Dividend Yield: 2.19%
• Price Target: $36.14
• Consensus Rating: Hold

Baxter International Stock Analysis - MarketRank™

Baxter International scored higher than 87% of companies evaluated by MarketBeat, and ranked 135th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Hold

Consensus Rating

Baxter International has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 4 buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Baxter International has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 10.08%

Earnings Growth

Earnings for Baxter International are expected to grow by 10.08% in the coming year, from $2.48 to $2.73 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Baxter International is -28.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Baxter International is -28.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Baxter International has a PEG Ratio of 0.91. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Baxter International has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.34% of the float of Baxter International has been sold short.

Short Interest Ratio / Days to Cover

Baxter International has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Baxter International has recently increased by 8.86%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Baxter International pays a meaningful dividend of 2.19%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Baxter International does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Baxter International will have a dividend payout ratio of 24.91% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -1.95

Percentage of Shares Shorted

3.34% of the float of Baxter International has been sold short.

Short Interest Ratio / Days to Cover

Baxter International has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Baxter International has recently increased by 8.86%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 1.36

News Sentiment

Baxter International has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Baxter International this week, compared to 8 articles on an average week.

Search Interest

Only 3 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Baxter International insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.21% of the stock of Baxter International is held by insiders.

Percentage Held by Institutions

90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BAX Stock Analysis - Frequently Asked Questions

How have BAX shares performed this year?

Baxter International's stock was trading at $29.16 at the beginning of 2025. Since then, BAX stock has increased by 6.6% and is now trading at $31.08.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) posted its quarterly earnings results on Thursday, May, 1st. The medical instruments supplier reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.14. Baxter International's revenue was up 5.4% compared to the same quarter last year.
Read the conference call transcript.

Does Baxter International have any subsidiaries?

The following companies are subsidiaries of Baxter International: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more.

Who are Baxter International's major shareholders?

Baxter International's top institutional investors include Park National Corp OH (0.04%). Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken and Jacqueline Kunzler.
View institutional ownership trends.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC).

Company Calendar

• Last Earnings: 5/01/2025
• Record date for 7/1 Dividend: 5/30/2025
• Ex-Dividend for 7/1 Dividend: 5/30/2025
• Dividend Payable: 7/01/2025
• Today: 7/05/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:BAX
• CIK: 10456
• Web: www.baxter.com
• Phone: (224) 948-2000
• Fax: 224-948-1813
• Employees: 38,000
• Year Founded: 1931

Price Target and Rating

• Average Stock Price Target: $36.14
• High Stock Price Target: $42.00
• Low Stock Price Target: $28.00
• Potential Upside/Downside: +16.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.38
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 12.53
• P/E Growth: 0.91
• Net Income: -$649 million
• Net Margins: -4.71%
• Pretax Margin: -2.84%
• Return on Equity: 17.24%
• Return on Assets: 5.12%

Debt

• Debt-to-Equity Ratio: 1.33
• Current Ratio: 2.02
• Quick Ratio: 1.40

Sales & Book Value

• Annual Sales: $10.64 billion
• Price / Sales: 1.50
• Cash Flow: $4.77 per share
• Price / Cash Flow: 6.52
• Book Value: $13.76 per share
• Price / Book: 2.26

Miscellaneous

• Outstanding Shares: 513,170,000
• Free Float: 512,097,000
• Market Cap: $15.95 billion
• Optionable: Optionable
• Beta: 0.61